2021 Investor Day

Sleep and Respiratory Care | Key takeaways Q 1 Leading market position to capture massive total addressable market for treatment of disordered sleep, COPD, asthma, and related diseases O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 2 Unique capability to improve the patient's experience of therapy and outcomes through the integration of device therapy and digital solutions. 3 Established reputation for reinventing the industry fuels our flywheel business and further leads to brand preference, patient access, and data to unlock insights and improve outcomes 42

View entire presentation